Longeveron Inc. is a biotechnology company that creates therapies for life-threatening and aging-related illnesses. They have developed LOMECEL-B, a cell-based therapy derived from young, healthy adult donors' bone marrow, and are trying it out during clinical trials for multiple conditions. The company is located in Miami, Florida, and was established in 2014.